Results

Total Results: 1,653 records

Showing results for "described".

221. Executive summary_Comparative Effectiveness Review No. 250_Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2024 Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-executive-sum.pdf
     January 01, 2024 - Program Methods Guide (https://effectivehealthcare.ahrq.gov/topics/cer-methods-guide/overview), as described … Results The included RCTs are described in Table B and the included observational studies are described

222. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-applicability.ppt
     June 01, 2012 - in practice and in studies Spectrum of disease in practice and in studies Source of population not described … The reviewer may be challenged when the population is not well described and key characteristics are … interpretation of test required in studies Version/ instrumentation not specified Training/quality control not described … Screening and diagnostic uses mixed Ultrasound machines and training of sonographers not described

223. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-applicability.ppt
     June 01, 2012 - in practice and in studies Spectrum of disease in practice and in studies Source of population not described … The reviewer may be challenged when the population is not well described and key characteristics are … interpretation of test required in studies Version/ instrumentation not specified Training/quality control not described … Screening and diagnostic uses mixed Ultrasound machines and training of sonographers not described

224. Making Sure That Evidence Is Understood and Used (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/epc-making-sure-evidence-understood.pdf
     July 01, 2020 - Comparison: ◆ The “C” in PICO(TS) describes what is being compared with the intervention described

225. Roadmap for Narratively Describing Effects of Interventions in Systematic Reviews | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/roadmap-interventions/white-paper

226. Partial Breast Irradiation for Breast Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/partial-breast-irradiation-disposition-comments.pdf
     January 31, 2023 - WBI in 10 fractions refers to patients who received WBI followed by a boost, as described in the … reflective of current practice, with widespread use of daily imaging, similar to the approach described … The limited data available for LVI is described in the results section and table J.13.

227. Disposition of Comments Report for Methods for Insulin Delivery and Glucose Monitoring (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-blood-sugar-2010_disposition-comments.pdf
     January 01, 2010 - This is described in our Methods. … The tools used to determine quality should be more clearly described. … Furthermore, it is described in Appendix B. … Peer Reviewer 1 Results, p. 57 The key messages are described explicitly. … The key points are well described and clear.

228. Disposition of Comments for Screening for Glaucoma: Comparative Effectiveness (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-screening_disposition-comments.pdf
     April 01, 2012 - A suitable comparison group (as described above) would be necessary to assess whether participation … as an included test) and line 51 (OCT 1 and OCT 2 imaging systems are described as excluded). … On this page, KQ3 is described in terms of “outcomes”— true positives, true negatives, false positives … Peer Reviewer #3 Results The severity of glaucoma included in the study (as described in “bi” above, … Peer Reviewer #3 Discussion Are the limitations of the review/studies described adequately?

229. Disposition of Comments Report for Whole-Body Vibration Therapy for Osteoporosis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-vibration-therapy_disposition-comments.pdf
     November 15, 2011 - Section Comment Response Peer Reviewer #1 Methods The inclusion and exclusion criteria are explicitly described

230. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-bone-fracture_research-protocol.pdf
     May 14, 2010 - in the Review We will adhere to four sets of inclusion/exclusion criteria; the first three are as described … As described for the first report,6 we will use a two-pronged approach to searching for relevant literature … Data Synthesis As described above, for comparisons for which we are able to identify three or more … outcomes, we will conduct pooled analyses as described in the original report.

231. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/bundled-payments-quality-effects_research-protocol.pdf
     June 23, 2011 - As described below, bundled payment systems vary in important ways, including the definition of the … Studies will be included that address the populations, interventions, comparators, and study outcomes described … o Extent to which valid primary outcomes were described. o Blinding of subjects and providers. … This additional domain does not need to be described or noted unless something ―implausible‖ has emerged

232. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/nppv-respiratory-failure_research-protocol.pdf
     April 21, 2011 - Data necessary for assessing quality and applicability, as described in the General Methods Guide, … To assess the methodological quality of individual studies, we will use the key criteria for RCTs described … The strength of evidence will be assessed by using the approach described in the General Methods … directly in KQ 4 (effect of setting, experience, patient characteristics) and by using the method described

233. Pharmacologic and Nonpharmacologic Treatments of Post-Traumatic Stress Disorder (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-protocol.pdf
     July 10, 2018 - Process for Selecting Studies: PICOTS described in Section II and criteria in Table 1 will be used to … We will construct an evidence table identifying the study characteristics (as described above) and results … Post-Traumatic Stress Disorder, some changes and additions were made to the data abstraction elements described … Process for Selecting Studies: PICOTS described in Section II and criteria in Table 1 will be used to

234. Pharmacologic and Nonpharmacologic Treatments of Post-Traumatic Stress Disorder (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-protocol.pdf
     July 10, 2018 - Process for Selecting Studies: PICOTS described in Section II and criteria in Table 1 will be used to … We will construct an evidence table identifying the study characteristics (as described above) and results … Post-Traumatic Stress Disorder, some changes and additions were made to the data abstraction elements described … Process for Selecting Studies: PICOTS described in Section II and criteria in Table 1 will be used to

235. Disposition of Comments for Interventions To Improve Cardiovascular Risk Factors in People With Serious Mental Illness (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-heart_disposition-comments.pdf
     April 22, 2013 - Peer Reviewer 3 Introduction Clear and issues well described Thank you. … Peer Reviewer 4 Methods The methods are solid and well described. … Yes Are the characteristics of the studies clearly described? … We considered PICOTS as described in our Methods when developing research priorities. … Yes Are the limitations of the review/studies described adequately?

236. ADHD-Update-protocol-160818 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-update_research-protocol.pdf
     August 18, 2016 - Rating scale results are intermediate monitoring outcomes, associated with the outcomes described below … o Comparators: Specific treatments will be compared to other included treatments as described above … KQ 2: Specific treatments will be compared to other treatments as described above or to no treatment … Data necessary for assessing quality and applicability, as described in the Methods Guide,28 will also … The strength of evidence will be assessed using the approach described in AHRQ’s Methods Guide.28 In

237. Disposition of Comments CER 185 Tympanostomy Tubes in Children With Otitis Media (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/tympanostomy-tubes-disposition.pdf
     May 05, 2017 - Hence, the two RCTs are described only and not shown in the forest plot. … Edited in Full Report to: "The Mattila 2003 paper described two groups, an RCT which randomly allocated … TEP/KI Reviewer #1 Discussion/Conclusion The findings and limitations are well described for each … The future research suggestions well described. Thank you. … Also, I found that the limitations of the review/studies were adequately described.

238. Disposition of Comments CER 185 Tympanostomy Tubes in Children With Otitis Media (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/tympanostomy-tubes-disposition.pdf
     May 05, 2017 - Hence, the two RCTs are described only and not shown in the forest plot. … Edited in Full Report to: "The Mattila 2003 paper described two groups, an RCT which randomly allocated … TEP/KI Reviewer #1 Discussion/Conclusion The findings and limitations are well described for each … The future research suggestions well described. Thank you. … Also, I found that the limitations of the review/studies were adequately described.

239. Methods-Guide-Chapter-Prioritization-And-Selection-Of-Harms-For-Inclusion-In-Systematic-Reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prioritization-selection-of-harms.pdf
     February 01, 2018 - No EPC report described the method used to select or prioritize harms, though most reported on serious … Few EPC reports described results for composite harms such as “any adverse event,” “withdrawal due to … No EPC report described using a formal prioritization process or the sources used to inform decisions … Although most KIs described a relatively informal process (e.g., soliciting general feedback from a … Several KIs also described using input from patient stakeholders.

240. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd-2005_executive.pdf
     January 01, 2005 - Higher adverse event rates were described for PPIs than for H2RAs or placebo. … Serious complications, including fatalities, have also been described. 4 Remaining Issues